[Significance of lymph node metastases in differentiated thyroid carcinoma]

Nuklearmedizin. 1995 Oct;34(5):203-6.
[Article in German]

Abstract

464 patients with differentiated thyroid carcinoma were scored and treated using a risk-oriented management scheme employing early surgical re-intervention including compartment-oriented lymph-node dissection in cases of lymph-node metastases or local recurrences without routine external radiotherapy. A multivariate analysis showed that there was no effect of lymph-node metastases on survival. The difference in survival between patients with (24%) and without (76%) lymph-node metastases (univariate analysis) were due to the coincidence of higher tumor stage (T4) and higher incidence of peripheral metastases (M1). Thus, provided surgery is efficient, N1 is not a risk factor influencing survival.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma, Follicular / diagnostic imaging
  • Adenocarcinoma, Follicular / mortality
  • Adenocarcinoma, Follicular / pathology
  • Adenocarcinoma, Follicular / surgery
  • Analysis of Variance
  • Carcinoma, Papillary / diagnostic imaging
  • Carcinoma, Papillary / mortality
  • Carcinoma, Papillary / pathology
  • Carcinoma, Papillary / surgery
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • Lymphatic Metastasis*
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Radiography
  • Reoperation
  • Risk Assessment
  • Survival Rate
  • Thyroid Neoplasms / diagnostic imaging*
  • Thyroid Neoplasms / mortality
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / surgery*

Substances

  • Iodine Radioisotopes